Table of Content

1 INTRODUCTION 
    1.1 OBJECTIVES OF THE STUDY 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY 
    1.5 LIMITATIONS 
    1.6 STAKEHOLDERS 
    1.7 SUMMARY OF CHANGES 
           1.7.1  RECESSION IMPACT
2 RESEARCH METHODOLOGY 
    2.1 RESEARCH DATA 
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
    2.2 MARKET ESTIMATION METHODOLOGY 
    2.3 MARKET GROWTH RATE PROJECTIONS 
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
    2.5 PRIMARY INSIGHTS 
    2.6 RESEARCH ASSUMPTIONS 
           2.6.1 IMPACT OF RECESSION
    2.7 RISK ANALYSIS 
3 EXECUTIVE SUMMARY 
4 PREMIUM INSIGHTS 
5 MARKET OVERVIEW 
    5.1 INTRODUCTION 
    5.2 MARKET SEGMENTATION 
    5.3 MARKET DYNAMICS 
           5.3.1 DRIVERS
           5.3.2 RESTRAINTS
           5.3.3 OPPORTUNITIES
           5.3.3 CHALLENGES
    5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES  
    5.5 PRICING ANALYSIS  
    5.6 TECHNOLOGY ANALYSIS  
    5.7 VALUE CHAIN ANALYSIS 
    5.8 SUPPLY CHAIN ANALYSIS 
    5.9 ECOSYSTEM ANALYSIS OF CELL THERAPY TECHNOLOGIES MARKET 
    5.10 KEY CONFERENCES AND EVENTS IN 2023–2024 
    5.11 REGULATORY ANALYSIS 
    5.12 PORTER’S FIVE FORCES ANALYSIS 
           5.12.1 THREAT FROM NEW ENTRANTS
           5.12.2 THREAT OF SUBSITITUTE
           5.12.3 BARGAINING POWER OF SUPPLERS 
           5.12.4  BARGAINING POWER OF BUYERS
           5.12.5  INTENSITY OF COMPETITION RIVARLY
    5.13 PATENT ANALYSIS 
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
6 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT  
    6.1 INTRODUCTION 
    6.2 MEDIA, SERA, AND REAGENTS 
    6.3 CELL ENGINEERING PRODUCTS 
    6.4 CELL CULTURE VESSELS 
    6.5 EQUIPMENT 
           6.5.1 CELL PROCESSING EQUIPMENT
           6.5.2 SINGLE-USE EQUIPMENT
           6.5.3 OTHER EQUIPMENTS
    6.6 SYSTEMS AND SOFTWARE 
    6.7 OTHER PRODUCTS7 
7 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS 
    7.1 INTRODUCTION  
    7.2 CELL PROCESSING 
    7.3 CELL PRESERVATION, DISTRIBUTION, AND HANDLING 
    7.4 PROCESS MONITORING AND QUALITY CONTROL  
8 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE 
    8.1 INTRODUCTION 
    8.2 T-CELLS 
    8.3 STEM CELLS 
    8.4 OTHER CELLS 
9 CELL THERAPY TECHNOLOGIES MARKET, BY END USER 
    9.1 INTRODUCTION 
    9.2 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 
    9.3 CROS & CMOS 
    9.4 RESEARCH INSTITUTES & CELL BANKS 
10 CELL THERAPY TECHNOLOGIES MARKET, BY REGION 
     10.1 INTRODUCTION 
     10.2 NORTH AMERICA 
             10.2.1 US
             10.2.2 CANADA
             10.2.3 RECESSION IMPACT
     10.3 EUROPE 
             10.3.1 GERMANY
             10.3.2 UK
             10.3.3 FRANCE
             10.3.4  REST OF EUROPE
             10.3.5 RECESSION IMPACT 
     10.4 ASIA PACIFIC 
             10.4.1 JAPAN
             10.4.2 CHINA
             10.4.3 INDIA
             10.4.4 REST OF APAC
             10.4.5 RECESSION IMPACT
     10.5 REST OF WORLD (ROW) 
             10.5.1 LATIN AMERICA
             10.5.2 MIDDLE EAST AND AFRICA
             10.5.3 RECESSION IMPACT
11 COMPETITIVE LANDSCAPE 
     11.1 INTRODUCTION  
     11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 
     11.3 MARKET SHARE ANALYSIS (2022) 
     11.4 REVENUE SHARE ANALYSIS 
     11.5 COMPANY EVALUATION QUADRANT: TOP 25 PLAYERS 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 EMERGING COMPANIES
     11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 
             11.6.1 COMPANY PRODUCT FOOTPRINT ANALYSIS
             11.6.2 COMPANY GEOGRAPHIC FOOTPRINT
     11.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES 
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
     11.8 COMPETATIVE BENCHMARKING OF STARTUP 
     11.9 COMPETITIVE SCENARIO AND TRENDS 
             11.9.1 PRODUCT LAUNCHES
             11.9.2 DEALS
             11.9.3 OTHERS DEVELOPMENT 
12 COMPANY PROFILES 
     12.1 KEY PLAYERS 
             12.1.1 THERMO FISHER SCIENTIFIC, INC. 
             12.1.2 MERCK KGAA
             12.1.3 DANAHER CORPORATION
             12.1.4 LONZA GROUP
             12.1.5 SARTORIUS AG
             12.1.6 TERUMO BCT, INC.
             12.1.7 BECTON, DICKINSON AND COMPANY
             12.1.8 FRESENIUS SE & CO. KGAA
             12.1.9 AVANTOR, INC.
             12.1.10 BIO-TECHNE CORPORATION
             12.1.11 CORNING INCORPORATED
             12.1.12 FUJIFILM IRVINE SCIENTIFIC
     12.2 OTHER COMPANIES 
             12.1.1  WERUM IT SOLUTIONS
             12.2.2  ROOSTERBIO, INC.
             12.2.3 SIRION BIOTECH GMBH
             12.2.4 TRAKCEL
             12.2.5 L7 INFORMATICS
             12.2.6 MILTENYI BIOTEC
             12.2.7 STEMCELL TECHNOLOGIES INC
             12.2.8 GPI IBERIA (FORMERLY HEMASOFT)
             12.2.9 MAK-SYSTEM
             12.3.10 ORGANABIO, LLC
             12.3.11 IXCELLS BIOTECHNOLOGY
             12.2.12 WILSON WOLF MANUFACTURING CORPORATION
13 APPENDIX 
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 AVAILABLE CUSTOMIZATIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS